Top

Quality of Life Research

Gepubliceerd in:

01-05-2008

Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools

Auteurs: Robert P. Finger, Monika Fleckenstein, Frank G. Holz, Hendrik P. N. Scholl

Gepubliceerd in: Quality of Life Research | Uitgave 4/2008

Abstract

Purpose

Age-related macular degeneration (AMD) has a considerable impact on older adults’ independence and autonomy. Recently, patient reported outcomes (PROs) such as QoL have been met with increasing interest by the scientific community, healthcare payers and planners. Against this background, the multitude of psychometric tools used to measure QoL in AMD was reviewed.

Methods

A search of the literature from 1990 onwards yielded 355 results, out of which 58 publications were included in the review. Data regarding design, validation and extent of utilization were obtained where available.

Results

The National Eye Institute–Visual Function Questionnaire (NEI VFQ-25-item) was found to be the most often used (29% of studies) and best validated psychometric tool, followed by the Visual Function Questionnaire (VF-14; 17%), and the Impact of Vision Impairment Profile (IVI; 9%). Most tools that were identified have been validated for the use in AMD patients.

Conclusion

Psychometric tools specifically designed to measure vision-related quality of life are well equipped and validated to measure QoL in AMD. More recent developments such as the Macular Disease-dependent Quality of Life (MacDQoL) questionnaire might be able to depict dimensions of vision-related QoL in greater depth. Future studies should endeavour to use a suggested standard when gathering data on vision related QoL, allowing for international comparisons.

vorige artikel Listen to their answers! Response behaviour in the measurement of physical and role functioning

volgende artikel The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ)

Fine S. L., Berger J. W., Maguire M. G., & Ho A. C. (2000). Age-related macular degeneration. The New England Journal of Medicine 342, 483–492.PubMedCrossRef

Trautner C., Haastert B., Richter B., Berger M., & Giani G. (2003). Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Investigative Ophthalmology & Visual Science, 44, 1031–1034.CrossRef

Birk T., Hickl S., Wahl H. W., Miller D., Kammerer A., Holz F., Becker S., & Volcker H. E. (2004). Development and pilot evaluation of a psychosocial intervention program for patients with age-related macular degeneration. Gerontologist, 44, 836–843.PubMed

de Jong P. T. (2006). Age-related macular degeneration. The New England Journal of Medicine, 355, 1474–1485.PubMedCrossRef

Holz F. G., Pauleikhoff D., Klein R., & Bird A. C. (2004). Pathogenesis of lesions in late age-related macular disease. American Journal of Ophthalmology, 137, 504–510.PubMedCrossRef

Eter N., Krohne T. U., & Holz F. G. (2006). New pharmacologic approaches to therapy for age-related macular degeneration. BioDrugs, 20, 167–179.PubMedCrossRef

The Age-related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology, 119, 1417–1436.

Slakter J. S., & Stur M. (2005). Quality of life in patients with age-related macular degeneration: Impact of the condition and benefits of treatment. Survey of Ophthalmology, 50, 263–273.PubMedCrossRef

Brody B. L., Gamst A. C., Williams R. A., Smith A. R., Lau P. W., Dolnak D., Rapaport M. H., Kaplan R. M., & Brown S. I. (2001). Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology, 108, 1893–1900, discussion 1900–1891.PubMedCrossRef

10.

Brody B. L., Williams R. A., Thomas R. G., Kaplan R. M., Chu R. M., & Brown S. I. (1999). Age-related macular degeneration: A randomized clinical trial of a self-management intervention. Annals of Behavioural Medicine, 21, 322–329.CrossRef

11.

Williams R. A., Brody B. L., Thomas R. G., Kaplan R. M., & Brown S. I. (1998). The psychosocial impact of macular degeneration. Archives of Ophthalmology, 116, 514–520.PubMed

12.

O’Shaughnessy J. A., Wittes R. E., Burke G., Friedman M. A., Johnson J. R., Niederhuber J. E., Rothenberg M. L., Woodcock J., Chabner B. A., & Temple R. (1991). Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. Journal of Clinical Oncology, 9, 2225–2232.PubMed

13.

Committee for Medicinal Products for Human Use (CHMP). (2005). Reflection Paper on the regulatory guidance for the use of healthrelated quality of life (HRQL) measures in the evaluation of medicinal products. In: EMEA, London.

14.

Chassany O., Sagnier P., Marquis P., Fullerton S., & Aaronson N. (2002). Patient—reported outcomes: The example of health-related quality of life—A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209–238.

15.

Cahill M. T., Banks A. D., Stinnett S. S., & Toth C. A. (2005). Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology, 112, 152–158.PubMedCrossRef

16.

Margolis M. K., Coyne K., Kennedy-Martin T., Baker T., Schein O., & Revicki D. A. (2002). Vision-specific instruments for the assessment of health-related quality of life and visual functioning: A literature review. Pharmacoeconomics, 20, 791–812.PubMedCrossRef

17.

de Boer M. R., Moll A. C., de Vet H. C., Terwee C. B., Volker-Dieben H. J., & van Rens G. H. (2004). Psychometric properties of vision-related quality of life questionnaires: A systematic review. Ophthalmic & Physiological Optics, 24, 257–273.CrossRef

18.

Mangione C. M., Phillips R. S., Seddon J. M., Lawrence M. G., Cook E. F., Dailey R., & Goldman L. (1992). Development of the ‘Activities of Daily Vision Scale’. A measure of visual functional status. Medical Care, 30, 1111–1126.PubMedCrossRef

19.

Pesudovs K., & Coster D. J. (1998). An instrument for assessment of subjective visual disability in cataract patients. The British Journal of Ophthalmology, 82, 617–624.PubMed

20.

Pesudovs K., Garamendi E., Keeves J. P., & Elliott D. B. (2003). The activities of daily vision scale for cataract surgery outcomes: Re-evaluating validity with Rasch analysis. Investigative Ophthalmology & Visual Science 44, 2892–2899.CrossRef

21.

Hart P. M., Chakravarthy U., Stevenson M. R., & Jamison J. Q. (1999). A vision specific functional index for use in patients with age related macular degeneration. The British Journal of Ophthalmology, 83, 1115–1120.PubMed

22.

Hart P. M., Stevenson M. R., Montgomery A. M., Muldrew K. A., & Chakravarthy U. (2005). Further validation of the daily living tasks dependent on vision: Identification of domains. The British Journal of Ophthalmology, 89, 1127–1130.PubMedCrossRef

23.

Schmier J. K., Halpern M. T., & Covert D. (2006). Validation of the daily living tasks dependent on vision (DLTV) questionnaire in a U.S. population with age-related macular degeneration. Ophthalmic Epidemiology, 13, 137–143.PubMedCrossRef

24.

McClure M. E., Hart P. M., Jackson A. J., Stevenson M. R., & Chakravarthy U. (2000). Macular degeneration: Do conventional measurements of impaired visual function equate with visual disability? The British Journal of Ophthalmology, 84, 244–250.PubMedCrossRef

25.

Lamoureux E. L., Pallant J. F., Pesudovs K., Rees G., Hassell J. B., & Keeffe J. E. (2007). The impact of vision impairment questionnaire: An assessment of its domain structure using confirmatory factor analysis and rasch analysis. Investigative Ophthalmology & Visual Science, 48, 1001–1006.CrossRef

26.

Lamoureux E. L., Pallant J. F., Pesudovs K., Hassell J. B., & Keeffe J. E. (2006). The impact of vision impairment questionnaire: An evaluation of its measurement properties using Rasch analysis. Investigative Ophthalmology & Visual Science, 47, 4732–4741.CrossRef

27.

Hassell J. B., Weih L. M., & Keeffe J. E. (2000). A measure of handicap for low vision rehabilitation: The impact of vision impairment profile. Clinical & Experiment Ophthalmology, 28, 156–161.CrossRef

28.

Mitchell J., & Bradley C. (2004). Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Quality of Life Research, 13, 1163–1175.PubMedCrossRef

29.

Mitchell J., Wolffsohn J. S., Woodcock A., Anderson S. J., McMillan C. V., Ffytche T., Rubinstein M., Amoaku W., & Bradley C. (2005). +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health and Quality of Life Outcomes, 3, 25.PubMedCrossRef

30.

Mangione C. M., Lee P. P., Gutierrez P. R., Spritzer K., Berry S., & Hays R. D. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119, 1050–1058.PubMed

31.

Miskala P. H., Hawkins B. S., Mangione C. M., Bass E. B., Bressler N. M., Dong L. M., Marsh M. J., & McCaffrey L. D. (2003). Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: Findings in patients with subfoveal choroidal neovascularization–SST Report No. 1. Archives of Ophthalmology, 121, 531–539.PubMedCrossRef

32.

Mangione C. M., Lee P. P., Pitts J., Gutierrez P., Berry S., & Hays R. D. (1998). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Archives of Ophthalmology, 116, 1496–1504.PubMed

33.

Mangione C. M., Berry S., Spritzer K., Janz N. K., Klein R., Owsley C., & Lee P. P. (1998). Identifying the content area for the 51-item national eye institute visual function questionnaire: Results from focus groups with visually impaired persons. Archives of Ophthalmology, 116, 227–233.PubMed

34.

Steinberg E. P., Tielsch J. M., Schein O. D., Javitt J. C., Sharkey P., Cassard S. D., Legro M. W., Diener-West M., Bass E. B., & Damiano A. M., et al. (1994). The VF-14. An index of functional impairment in patients with cataract. Archives of Ophthalmology, 112, 630–638.PubMed

35.

Linder M., Chang T. S., Scott I. U., Hay D., Chambers K., Sibley L. M., & Weis E. (1999). Validity of the visual function index (VF-14) in patients with retinal disease. Archives of Ophthalmology, 117, 1611–1616.PubMed

36.

Riusala A., Sarna S., & Immonen I. (2003). Visual function index (VF-14) in exudative age-related macular degeneration of long duration. American Journal of Ophthalmology, 135, 206–212.PubMedCrossRef

37.

Cassard S. D., Patrick D. L., Damiano A. M., Legro M. W., Tielsch J. M., Diener-West M., Schein O. D., Javitt J. C., Bass E. B., & Steinberg E. P. (1995). Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Archives of Ophthalmology, 113, 1508–1513.PubMed

38.

Lindblad A. S., & Clemons T. E. (2005). Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Archives of Ophthalmology, 123, 1207–1214.PubMedCrossRef

39.

Clemons T. E., Chew E. Y., Bressler S. B., & McBee W. (2003). National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Archives of Ophthalmology, 121, 211–217.PubMed

40.

Suzukamo Y., Oshika T., Yuzawa M., Tokuda Y., Tomidokoro A., Oki K., Mangione C. M., Green J., & Fukuhara S. (2005). Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health and Quality of Life Outcomes, 3, 65.PubMedCrossRef

41.

Toprak A. B., Eser E., Guler C., Baser F. E., & Mayali H. (2005). Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiology, 12, 259–269.PubMedCrossRef

42.

Rossi G. C., Milano G., & Tinelli C. (2003). The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: Translation, validity, and reliability. Journal of Glaucoma, 12, 213–220.PubMedCrossRef

43.

Hudson H. L., Lane S. S., Heier J. S., Stulting R. D., Singerman L., Lichter P. R., Sternberg P., & Chang D. F. (2006). Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-Year results. Ophthalmology, 113, 1987–2001.PubMedCrossRef

44.

Fuhs A., Dasch B., Behrens T., Meister A., Krause K., Pauleikhoff D., & Hense H. W. (2005). Visual function and quality of life in patients with age-related maculopathy: Results of the Munster Age and Retina Study (MARS). Klin Monatsbl Augenheilkd, 222, 649–654.PubMedCrossRef

45.

Cahill M. T., Stinnett S. S., Banks A. D., Freedman S. F., & Toth C. A. (2005). Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology, 112, 144–151.PubMedCrossRef

46.

Miskala P. H., Bass E. B., Bressler N. M., Childs A. L., Hawkins B. S., Mangione C. M., & Marsh M. J. (2004). Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Quality-of-life findings: SST report no. 12. Ophthalmology, 111, 1981–1992.PubMedCrossRef

47.

Childs A. L., Bressler N. M., Bass E. B., Hawkins B. S., Mangione C. M., Marsh M. J., & Miskala P. H. (2004). Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Quality-of-life findings: SST report no. 14. Ophthalmology, 111, 2007–2014.PubMedCrossRef

48.

Scilley K., DeCarlo D. K., Wells J., & Owsley C. (2004). Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services. Ophthalmic Epidemiology, 11, 131–146.PubMedCrossRef

49.

Dong L. M., Childs A. L., Mangione C. M., Bass E. B., Bressler N. M., Hawkins B. S., Marsh M. J., Miskala P., Jaffee H. A., & McCaffrey L. A. (2004). Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. American Journal of Ophthalmology, 138, 91–108.PubMedCrossRef

50.

Maguire M. (2004). Baseline characteristics, the 25-item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology, 111, 1307–1316.PubMedCrossRef

51.

Varma R., Paz S. H., Azen S. P., Klein R., Globe D., Torres M., Shufelt C., & Preston-Martin S. (2004). The Los Angeles Latino Eye Study: Design, methods, and baseline data. Ophthalmology, 111, 1121–1131.PubMedCrossRef

52.

DeCarlo D. K., Scilley K., Wells J., & Owsley C. (2003). Driving habits and health-related quality of life in patients with age-related maculopathy. Optom Vis Sci, 80, 207–213.PubMedCrossRef

53.

Berdeaux G. H., Nordmann J. P., Colin E., & Arnould B. (2005). Vision-related quality of life in patients suffering from age-related macular degeneration. American Journal of Ophthalmology, 139, 271–279.PubMedCrossRef

54.

Brody B. L., Roch-Levecq A. C., Thomas R. G., Kaplan R. M., & Brown S. I. (2005). Self-management of age-related macular degeneration at the 6-month follow-up: A randomized controlled trial. Archives of Ophthalmology, 123, 46–53.PubMedCrossRef

55.

Brody B. L., Roch-Levecq A. C., Gamst A. C., Maclean K., Kaplan R. M., & Brown S. I. (2002). Self-management of age-related macular degeneration and quality of life: A randomized controlled trial. Archives of Ophthalmology, 120, 1477–1483.PubMed

56.

Miskala P. H., Bressler N. M., & Meinert C. L. (2004). Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Archives of Ophthalmology, 122, 758–766.PubMedCrossRef

57.

Bansback N., Czoski-Murray C., Carlton J., Lewis G., Hughes L., Espallargues M., Brand C., & Brazier J. (2007). Determinants of health related quality of life and health state utility in patients with age related macular degeneration: The association of contrast sensitivity and visual acuity. Quality of Life Research, 16, 533–543.PubMedCrossRef

58.

Pham T. Q., Cugati S., Rochtchina E., Mitchell P., Maloof A., & Wang J. J. (2007). Age-related maculopathy and cataract surgery outcomes: Visual acuity and health-related quality of life. Eye, 21, 324–330.PubMedCrossRef

59.

Hewitt A. W., Jeganathan V. S., Kidd J. E., Pesudovs K., & Verma N. (2006). Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes Archive for Clinical and Experimental Ophthalmology, 244, 972–977.CrossRef

60.

Armbrecht A. M., Aspinall P. A., & Dhillon B. (2004). A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. The British Journal of Ophthalmology 88, 1270–1273.PubMedCrossRef

61.

Armbrecht A. M., Findlay C., Aspinall P. A., Hill A. R., & Dhillon B. (2003). Cataract surgery in patients with age-related macular degeneration: One-year outcomes. Journal of Cataract and Refractive Surgery, 29, 686–693.PubMedCrossRef

62.

Mackenzie P. J., Chang T. S., Scott I. U., Linder M., Hay D., Feuer W. J., & Chambers K. (2002). Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology, 109, 720–729.PubMedCrossRef

63.

Armbrecht A. M., Findlay C., Kaushal S., Aspinall P., Hill A. R., & Dhillon B. (2000). Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. The British Journal of Ophthalmology, 84, 1343–1348.PubMedCrossRef

64.

Scott I. U., Smiddy W. E., Schiffman J., Feuer W. J., Pappas & C. J. (1999). Quality of life of low-vison patients and the impact of low-vision services. American Journal of Ophthalmology, 128, 54–62.PubMedCrossRef

65.

Weih L. M., Hassell J. B., & Keeffe J. E. (2002). Assessment of the impact of vision impairment. Investigative Ophthalmology & Visual Science, 43, 927–935.

66.

Keeffe J. E., McCarty C. A., Hassell J. B., & Gilbert A. G. (1999). Description and measurement of handicap caused by vision impairment. Australian and New Zealand Journal of Ophthalmology, 27, 184–186.PubMedCrossRef

67.

Hassell J. B., Lamoureux E. L., & Keeffe J. E. (2006). Impact of age related macular degeneration on quality of life. The British Journal of Ophthalmology, 90, 593–596.PubMedCrossRef

68.

Lamoureux E. L., Hassell J. B., & Keeffe J. E. (2004). The determinants of participation in activities of daily living in people with impaired vision. American Journal of Ophthalmology, 137, 265–270.PubMedCrossRef

69.

Stevenson M. R., Hart P. M., Chakravarthy U., Mackenzie G., Bird A. C., Owens S. L., Chisholm I. H., Hall V., Houston R. F., McCulloch D. W., & Plowman N. (2005). Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2. The British Journal of Ophthalmology, 89, 1045–1051.PubMedCrossRef

70.

Stevenson M. R., Hart P. M., Montgomery A. M., McCulloch D. W., & Chakravarthy U. (2004). Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. The British Journal of Ophthalmology, 88, 1125–1130.PubMedCrossRef

71.

Mangione C. M., Gutierrez P. R., Lowe G., Orav E. J., & Seddon J. M. (1999). Influence of age-related maculopathy on visual functioning and health-related quality of life. American Journal of Ophthalmology, 128, 45–53.PubMedCrossRef

72.

Lane S. S., Kuppermann B. D., Fine I. H., Hamill M. B., Gordon J. F., Chuck R. S., Hoffman R. S., Packer M., & Koch D. D. (2004). A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope. American Journal of Ophthalmology, 137, 993–1001.PubMedCrossRef

73.

Hazel C. A., Petre K. L., Armstrong R. A., Benson M. T., & Frost N. A. (2000). Visual function and subjective quality of life compared in subjects with acquired macular disease. Investigative Ophthalmology & Visual Science, 41, 1309–1315.

74.

Reeves B. C., Harper R. A., & Russell W. B. (2004). Enhanced low vision rehabilitation for people with age related macular degeneration: A randomised controlled trial. The British Journal of Ophthalmology, 88, 1443–1449.PubMedCrossRef

75.

Krummenauer F., Braun M., & Dick H. B. (2005). Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration. European Journal of Ophthalmology, 15, 74–80.PubMed

76.

Lundstrom M., Brege K. G., Floren I., Lundh B., Stenevi U., & Thorburn W. (2002). Cataract surgery and quality of life in patients with age related macular degeneration. The British Journal of Ophthalmology, 86, 1330–1335.PubMedCrossRef

77.

Carta A., Braccio L., Belpoliti M., Soliani L., Sartore F., Gandolfi S. A., & Maraini G. (1998). Self-assessment of the quality of vision: Association of questionnaire score with objective clinical tests. Current Eye Research, 17, 506–511.PubMedCrossRef

78.

Gupta S. K., Viswanath K., Thulasiraj R. D., Murthy G. V., Lamping D. L., Smith S. C., Donoghue M., & Fletcher A. E. (2005). The development of the Indian vision function questionnaire: Field testing and psychometric evaluation. The British Journal of Ophthalmology, 89, 621–627.PubMedCrossRef

79.

Alonso J., Espallargues M., Andersen T. F., Cassard S. D., Dunn E., Bernth-Petersen P., Norregaard J. C., Black C., Steinberg E. P., & Anderson G. F. (1997). International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology, 104, 799–807.PubMed

80.

Crabtree H. L., Hildreth A. J., O’Connell J. E., Phelan P. S., Allen D., & Gray C. S. (1999). Measuring visual symptoms in British cataract patients: The cataract symptom scale. The British Journal of Ophthalmology, 83, 519–523.PubMedCrossRef

81.

Fitzpatrick R., Davey C., Buxton M. J., & Jones D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2, i, iv–1, 74.

82.

Pallant J. F., & Tennant A. (2007). An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). The British Journal of Clinical Psychology, 46, 1–18.PubMedCrossRef

83.

Massof R. W., & Fletcher D. C. (2001). Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Research, 41, 397–413.PubMedCrossRef

84.

Langelaan M., van Nispen R. M., Knol D. L., Moll A. C., de Boer M. R., Wouters B., & van Rens G. H. (2007). Visual Functioning Questionnaire: Reevaluation of psychometric properties for a group of working-age adults. Optometry and Vision Science 84, 775–784.PubMedCrossRef

85.

Denny F., Marshall A. H., Stevenson M. R., Hart P. M., & Chakravarthy U. (2007). Rasch analysis of the daily living tasks dependent on vision (DLTV). Investigative Ophthalmology & Visual Science, 48, 1976–1982.CrossRef

86.

Velozo C. A., Lai J. S., Mallinson T., & Hauselman E. (2000). Maintaining instrument quality while reducing items: Application of Rasch analysis to a self-report of visual function. Journal of Outcome Measurement, 4, 667–680.PubMed

Titel: Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools
Auteurs: Robert P. Finger
Monika Fleckenstein
Frank G. Holz
Hendrik P. N. Scholl
Publicatiedatum: 01-05-2008
Uitgeverij: Springer Netherlands
Gepubliceerd in: Quality of Life Research / Uitgave 4/2008
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-008-9327-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2008

Reliability and validity of childhood asthma control test in a population of Chinese asthmatic children

Identifying response shift statistically at the individual level

The development of the pediatric cardiac quality of life inventory: a quality of life measure for children and adolescents with heart disease

Individual quality of life: adaptive conjoint analysis as an alternative for direct weighting?

Health-related quality of life following blind rehabilitation

Listen to their answers! Response behaviour in the measurement of physical and role functioning